| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590856 | Multiple Sclerosis and Related Disorders | 2017 | 15 Pages |
Abstract
Beyond a positive/borderline/negative result, the titer of the anti-AQP4 antibody ELISA assay is not predictive in the disease course for patients with NMOSD. Low titer patients experience the same disease course as medium-titer and high-titer anti-AQP4 antibody patients with NMOSD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Remi A. Kessler, Maureen A. Mealy, Jorge Andres Jimenez-Arango, Chao Quan, Friedemann Paul, Reydmar López, Sarah Hopkins, Michael Levy,